Clinical trial
Positioning Imatinib for Pulmonary Arterial Hypertension
NCT04416750 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Positioning Imatinib for Pulmonary Arterial Hypertension
- Lead sponsor
- Imperial College London
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 20, 2021
- Completion date
- July 1, 2024
- Enrollment
- 17 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.